GWMI
SGMO

Guardian Wealth Management (Illinois)’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Guardian Wealth Management (Illinois)’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-230
Closed -$125 – 258
2023
Q4 		$125 Hold
230
– – ﹤0.01% 249
2023
Q3 		$138 Hold
230
– – ﹤0.01% 221
2023
Q2 		$299 Hold
230
– – ﹤0.01% 220
2023
Q1 		$405 Hold
230
– – ﹤0.01% 231
2022
Q4 		$722 Hold
230
– – ﹤0.01% 235
2022
Q3 		$1K Hold
230
– – ﹤0.01% 225
2022
Q2 		$1K Hold
230
– – ﹤0.01% 213
2022
Q1 		$1K Hold
230
– – ﹤0.01% 223
2021
Q4 		$2K Buy
+230
New +$2K ﹤0.01% 206

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Guardian Wealth Management (Illinois)'s SGMO Position: Q1 2024 in Review

Guardian Wealth Management (Illinois) sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2024, closing a stake of 230 shares — an estimated $125 sold.

Guardian Wealth Management (Illinois) first reported a position in SGMO in Q4 2021 and held it in 9 quarters. The position peaked at $2K in Q4 2021. 131 funds tracked by Wall St. Rank hold SGMO as of Q1 2024.

  • Guardian Wealth Management (Illinois) reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2024 after selling out during the quarter.
  • Guardian Wealth Management (Illinois) sold 230 SANGAMO THERAPEUTICS INC shares in Q1 2024, an estimated $125.
  • Guardian Wealth Management (Illinois) first reported a position in SANGAMO THERAPEUTICS INC in Q4 2021 and held it in 9 quarters.
  • Guardian Wealth Management (Illinois)'s SANGAMO THERAPEUTICS INC position peaked at $2K in Q4 2021.
  • 131 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2024.

Based on Guardian Wealth Management (Illinois)'s 13F filing for Q1 2024, filed 14 May 2024.